Fig. 2From: Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab200x magnification. Skin biopsy demonstrating interface dermatitis with eosinophils, necrotic keratinocytes, and full-thickness epidermal necrosis, compatible with SJS/TEN in a 63-year-old man with non-small cell lung cancerBack to article page